Byonyks
Franklin Rudolph is a highly experienced professional in the fields of engineering and music, currently serving as the Founding Partner and Chief Electrical Engineer at Byonyks, a medical devices company focused on improving patient outcomes. With a diverse career spanning decades, Franklin has held various roles such as an Inventor and Developer in self-employment, a musician and luthier at Rudolph Violins, and an Affiliate Faculty Member at the University of New Hampshire. Previous positions include Utility Engineer for the Vermont Public Utilities Commission, Senior Software Engineer at Numia Medical Technology, and Senior Embedded Systems Engineer at Beacon Power. Franklin holds a Ph.D. in Electrical Engineering and Computer Science and a BS in Mechanical Engineering from the University of South Alabama, along with significant contributions to both academia and the engineering sector.
This person is not in any teams
This person is not in any offices
Byonyks
Byonyks has pioneered the world’s first affordable Bloodless Dialysis machine, transforming care for kidney failure patients. Globally, over eight million people with kidney disease lack dialysis access—a costly, invasive, and time-consuming treatment that filters blood when kidneys fail. Many of these individuals face life-threatening consequences due to the lack of proper care. Byonyks addresses this critical issue with its Bloodless Dialysis machine; a safe, effective, portable, and non-invasive solution that’s more affordable than existing options. Our technology empowers patients to perform dialysis at home, overnight, while they sleep, allowing them to maintain their daily work and family responsibilities. The needle-free approach also reduces the risk of chronic infections such as HIV and Hepatitis C. Headquartered in the USA and South Asia, Byonyks is a medical device startup founded by Harvard/MIT graduates and industry experts. Our core team’s expertise contributes to over half of the operational peritoneal dialysis machines worldwide. The groundbreaking Bloodless Dialysis machine has saved multiple lives in South Asia and is currently under FDA review—a pivotal step towards making accessible kidney care a global reality.